CDH2 and breast carcinoma: In this study, LINC00665 reduced the expression of E-cadherin and induced the expression of N-cadherin and vimentin, whereas knockdown of endogenous LINC00665 produced the opposite effects in breast cancer cells, suggesting that LINC00665 is an inducer of EMT in breast cancer.